Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $54,250 | 28 | 85.5% |
| Food and Beverage | $4,810 | 285 | 7.6% |
| Travel and Lodging | $4,299 | 14 | 6.8% |
| Education | $105.65 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $48,849 | 156 | $0 (2021) |
| PFIZER INC. | $12,147 | 30 | $0 (2021) |
| Allergan, Inc. | $487.85 | 45 | $0 (2020) |
| Amgen Inc. | $462.36 | 27 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $319.29 | 16 | $0 (2019) |
| ACADIA Pharmaceuticals Inc | $207.56 | 4 | $0 (2019) |
| AMAG Pharmaceuticals, Inc. | $157.84 | 3 | $0 (2019) |
| Astellas Pharma US Inc | $130.40 | 5 | $0 (2018) |
| Avanir Pharmaceuticals, Inc. | $129.79 | 2 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $77.09 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14.88 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($14.88) |
| 2021 | $2,020 | 2 | PFIZER INC. ($1,900) |
| 2020 | $3,531 | 4 | PFIZER INC. ($3,450) |
| 2019 | $20,084 | 66 | Janssen Pharmaceuticals, Inc ($12,862) |
| 2018 | $10,124 | 113 | Janssen Pharmaceuticals, Inc ($9,245) |
| 2017 | $27,690 | 143 | Janssen Pharmaceuticals, Inc ($26,621) |
All Payment Transactions
329 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: DIABETES | ||||||
| 12/23/2021 | PFIZER INC. | COLOGUARD DNA CAPTURE REAGENTS (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,900.00 | General |
| Category: GASTROINTESTINAL | ||||||
| 10/29/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/25/2020 | PFIZER INC. | COLOGUARD (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,150.00 | General |
| Category: GASTROINTESTINAL | ||||||
| 02/21/2020 | PFIZER INC. | COLOGUARD (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,150.00 | General |
| Category: GASTROINTESTINAL | ||||||
| 02/13/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $81.37 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2020 | PFIZER INC. | COLOGUARD (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,150.00 | General |
| Category: GASTROINTESTINAL | ||||||
| 12/27/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,050.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/16/2019 | PFIZER INC. | COLOGUARD (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,900.00 | General |
| Category: GASTROINTESTINAL | ||||||
| 12/11/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,050.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/11/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,050.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/06/2019 | PFIZER INC. | COLOGUARD (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,150.00 | General |
| Category: GASTROINTESTINAL | ||||||
| 12/05/2019 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $10.14 | General |
| Category: GASTROINTESTINAL | ||||||
| 12/04/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $100.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/02/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/22/2019 | PFIZER INC. | COLOGUARD (Device) | Travel and Lodging | In-kind items and services | $782.10 | General |
| Category: GASTROINTESTINAL | ||||||
| 11/21/2019 | PFIZER INC. | COLOGUARD (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,900.00 | General |
| Category: GASTROINTESTINAL | ||||||
| 11/16/2019 | PFIZER INC. | COLOGUARD (Device) | Travel and Lodging | In-kind items and services | $729.06 | General |
| Category: GASTROINTESTINAL | ||||||
| 11/14/2019 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $108.51 | General |
| Category: GASTROINTESTINAL | ||||||
| 11/07/2019 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $74.41 | General |
| Category: GASTROINTESTINAL | ||||||
| 10/31/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $74.08 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/17/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $98.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/28/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,050.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/23/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $102.17 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/21/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $70.76 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 838 | 2,049 | $232,060 | $74,552 |
| 2022 | 20 | 768 | 1,922 | $224,824 | $72,385 |
| 2021 | 26 | 1,036 | 2,659 | $311,729 | $97,317 |
| 2020 | 30 | 1,631 | 5,508 | $512,006 | $162,855 |
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 173 | 263 | $46,814 | $20,543 | 43.9% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 120 | 135 | $38,880 | $13,328 | 34.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 52 | 52 | $13,156 | $6,246 | 47.5% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 49 | 80 | $16,000 | $5,118 | 32.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 41 | 93 | $20,040 | $4,412 | 22.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 30 | 43 | $8,600 | $3,116 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 51 | $6,069 | $2,917 | 48.1% |
| 76882 | Limited ultrasound scan of joint or other extremity structure except blood vessels | Office | 2023 | 30 | 96 | $9,600 | $2,895 | 30.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 20 | 21 | $3,948 | $2,800 | 70.9% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 29 | 33 | $9,504 | $2,735 | 28.8% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 28 | 41 | $19,024 | $1,622 | 8.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 22 | 31 | $4,712 | $1,540 | 32.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 20 | 20 | $1,690 | $1,432 | 84.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 27 | $1,863 | $998.88 | 53.6% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 22 | 37 | $6,401 | $965.35 | 15.1% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 25 | 42 | $6,468 | $797.04 | 12.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 48 | 900 | $12,600 | $737.95 | 5.9% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 11 | 13 | $1,976 | $661.92 | 33.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 15 | 17 | $2,363 | $656.71 | 27.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 20 | $1,080 | $572.60 | 53.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 11 | 22 | $1,056 | $356.84 | 33.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 11 | 12 | $216.00 | $100.80 | 46.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 158 | 261 | $46,458 | $22,569 | 48.6% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Office | 2022 | 80 | 92 | $26,496 | $8,617 | 32.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 56 | 56 | $14,168 | $6,996 | 49.4% |
About Dr. Karl Sash, MD
Dr. Karl Sash, MD is a Internal Medicine healthcare provider based in Evansville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1902883291.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Karl Sash, MD has received a total of $63,464 in payments from pharmaceutical and medical device companies, with $14.88 received in 2024. These payments were reported across 329 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($54,250).
As a Medicare-enrolled provider, Sash has provided services to 4,273 Medicare beneficiaries, totaling 12,138 services with total Medicare billing of $407,109. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospice and Palliative Medicine, Geriatric Medicine
- Location Evansville, IN
- Active Since 12/28/2005
- Last Updated 08/15/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1902883291
Products in Payments
- INVOKANA (Drug) $47,894
- COLOGUARD (Device) $10,104
- COLOGUARD DNA CAPTURE REAGENTS (Device) $1,900
- XARELTO (Drug) $954.93
- ENTRESTO (Drug) $295.81
- Prolia (Biological) $259.06
- NUPLAZID (Drug) $207.56
- INTRAROSA (Drug) $157.84
- Repatha (Biological) $150.58
- VIBERZI (Drug) $148.67
- NAMZARIC (Drug) $144.32
- NUEDEXTA (Drug) $129.79
- VRAYLAR (Drug) $104.92
- LINZESS (Drug) $71.63
- LONHALA MAGNAIR (Drug) $67.51
- LYRICA (Drug) $44.26
- Synthroid (Drug) $40.43
- JANUVIA (Drug) $33.20
- PRALUENT ALIROCUMAB INJECTION (Biological) $32.75
- DIFICID (Drug) $31.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Evansville
Dr. Douglas Sheffer, Md, MD
Internal Medicine — Payments: $77,392
Dr. Narothama Reddy Aeddula, Md, MD
Internal Medicine — Payments: $75,760
Adeel Siddiqui, M.d, M.D
Internal Medicine — Payments: $21,524
Anthony Voelkel, Md, MD
Internal Medicine — Payments: $19,840
Dr. James Evanson, Md, MD
Internal Medicine — Payments: $17,125
Cameron Whitler, D.o, D.O
Internal Medicine — Payments: $15,807